Abdominal Pain News and Research

RSS
Abdominal pain is traditionally described by its chronicity (acute or chronic), its progression over time, its nature (sharp, dull, colicky), its distribution (by various methods, such as abdominal quadrant (left upper quadrant, left lower quadrant, right upper quadrant, right lower quadrant) or other methods that divide the abdomen into nine sections), and by characterization of the factors that make it worse, or alleviate it.
ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

ViroPharma commences VP 20621 Phase 2 study for prevention of recurrent Clostridium difficile infection

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Simple home-based colon cancer screening test can prevent many unnecessary deaths in Canada

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

Pfizer's axitinib Phase 3 trial in advanced renal cell carcinoma meets primary endpoints

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

Irritable Bowel Syndrome linked to bacterial overgrowth, food poisoning

Study finds strong link between live birth rates and number of eggs retrieved in one IVF cycle

Study finds strong link between live birth rates and number of eggs retrieved in one IVF cycle

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

Study confirms LcS-fermented milk reduces fever linked with acute norovirus gastroenteritis

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

Abbott, Sucampo present lubiprostone phase 3 trial data in Japanese CIC at DDW 2011

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

FDA approves Afinitor for treatment of progressive neuroendocrine tumors in the pancreas

H. pylori DNA may help treat severe colitis

H. pylori DNA may help treat severe colitis

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Fecal transplant procedures performed at Sinai Hospital

Fecal transplant procedures performed at Sinai Hospital

Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension

Pfizer’s Revatio receives European Commission approval for pediatric treatment of pulmonary arterial hypertension

Lead investigator to discuss growing impact of AFib on US health care costs and resources

Lead investigator to discuss growing impact of AFib on US health care costs and resources

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

AstraZeneca receives FDA approval for NEXIUM I.V. to treat GERD with erosive esophagitis

Bioniche Life Sciences opens new livestock vaccine manufacturing facility

Bioniche Life Sciences opens new livestock vaccine manufacturing facility

ED providers need to assess STI risks in adolescents: Instructor of pediatrics

ED providers need to assess STI risks in adolescents: Instructor of pediatrics

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

Antiviral Drugs Advisory Committee recommends FDA to approve telaprevir for hepatitis C

More women using ‘morning after’ pill

More women using ‘morning after’ pill

Nausea and vomiting are most feared of all chemotherapy-related side effects

Nausea and vomiting are most feared of all chemotherapy-related side effects

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

AstraZeneca announces U.S. availability of vandetanib for rare medullary thyroid cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.